WBCPJ:AU:AU-Westpac Banking Corporation (AUD)

CAPITAL NOTES | |

Last Closing

USD 103.66

Change

0.00 (0.00)%

Market Cap

USD 83.23B

Volume

4.67K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-29 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
CBAPI:AU Commonwealth Bank of Australia..

-0.75 (-0.72%)

USD 191.08B
CBAPG:AU Commonwealth Bank of Australia..

+0.23 (+0.22%)

USD 175.86B
CGFPC:AU Challenger Ltd Preferred

+0.31 (+0.30%)

USD 4.44B
MGF:AU Magellan Global Fund Unit

-0.07 (-3.10%)

USD 2.85B
LSF:AU L1 Long Short Fund Ltd

-0.05 (-1.57%)

USD 1.95B
ASK:AU ABACUS STORAGE KING

+0.01 (+0.87%)

USD 1.54B
VG1:AU VGI Partners Global Investment..

-0.02 (-0.78%)

USD 0.79B
KKC:AU Kkr Credit Income Fund

N/A

USD 0.73B
RF1:AU Regal Investment Fund

-0.05 (-1.55%)

USD 0.54B
PCI:AU Perpetual Credit Income Trust

+0.01 (+0.44%)

USD 0.43B

ETFs Containing WBCPJ:AU

SUBD:AU VanEck Australian Subordi.. 5.49 % 0.00 %

-0.10 (-0.79%)

USD 1.38B
US3:PA 4.97 % 0.00 %

N/A

N/A
GERM ETFMG Treatments Testing .. 4.53 % 0.00 %

+0.14 (+-0.79%)

USD 0.01B
US1:PA 2.18 % 0.00 %

N/A

N/A
CNCR Loncar Cancer Immunothera.. 2.07 % 0.79 %

+0.17 (+-0.79%)

USD 0.01B
FLOT:AU VanEck Australian Floatin.. 1.82 % 0.00 %

-0.07 (-0.79%)

USD 0.69B
BBP Virtus LifeSci Biotech Pr.. 1.78 % 0.79 %

+0.31 (+-0.79%)

USD 0.02B
UEFZ:F UBS ETF SICAV - SBI Forei.. 1.53 % 0.00 %

-0.13 (-0.79%)

USD 0.42B
UEFZ:XETRA UBS - SBI Foreign AAA-BBB.. 1.53 % 0.00 %

-0.13 (-0.79%)

USD 0.42B
F5ESG:SW UBS(Lux)Fund Solutions .. 1.53 % 0.00 %

-0.11 (-0.79%)

USD 0.42B
FYC First Trust Small Cap Gro.. 0.79 % 0.70 %

-0.23 (-0.79%)

USD 0.27B
FYX First Trust Small Cap Cor.. 0.40 % 0.63 %

-0.60 (-0.79%)

USD 0.84B
XCCC BondBloxx ETF Trust 0.05 % 0.00 %

-0.43 (-0.79%)

USD 0.06B

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.01% N/A N/A 59% D-
Dividend Return 2.63% N/A N/A 66% D+
Total Return 2.64% N/A N/A 61% D-
Trailing 12 Months  
Capital Gain 1.64% N/A N/A 59% D-
Dividend Return 5.30% N/A N/A 67% D+
Total Return 6.93% N/A N/A 62% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.00% N/A N/A 42% F
Dividend Return 2.21% N/A N/A 45% F
Total Return 2.20% N/A N/A 43% F
Risk Return Profile  
Volatility (Standard Deviation) 2.72% N/A N/A 98% N/A
Risk Adjusted Return 81.22% N/A N/A 96% N/A
Market Capitalization 83.23B N/A N/A 99% N/A

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Negative cashflow

The company had negative total cash flow in the most recent four quarters.